Works matching IS 03407004 AND DT 2024 AND VI 73 AND IP 2

Results: 20

Enhanced T cell immune activity mediated by Drp1 promotes the efficacy of PD-1 inhibitors in treating lung cancer.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03582-5
By:
- Ma, Jietao;
- Song, Jun;
- Yi, Xiaofang;
- Zhang, Shuling;
- Sun, Li;
- Huang, Letian;
- Han, Chengbo
Publication type:
Article
Updated systematic review and network meta-analysis of first-line treatments for metastatic renal cell carcinoma with extended follow-up data.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03621-1
By:
- Yanagisawa, Takafumi;
- Mori, Keiichiro;
- Matsukawa, Akihiro;
- Kawada, Tatsushi;
- Katayama, Satoshi;
- Bekku, Kensuke;
- Laukhtina, Ekaterina;
- Rajwa, Pawel;
- Quhal, Fahad;
- Pradere, Benjamin;
- Fukuokaya, Wataru;
- Iwatani, Kosuke;
- Murakami, Masaya;
- Bensalah, Karim;
- Grünwald, Viktor;
- Schmidinger, Manuela;
- Shariat, Shahrokh F.;
- Kimura, Takahiro
Publication type:
Article
Adipose-derived stem cell exosomes promote tumor characterization and immunosuppressive microenvironment in breast cancer.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03584-3
By:
- Zhu, Qin;
- Cao, Yukun;
- Yuan, Jiaqi;
- Hu, Yu
Publication type:
Article
A comprehensive pan-cancer analysis of prognostic value and potential clinical implications of FTH1 in cancer immunotherapy.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03625-x
By:
- Luo, Yuejun;
- Liu, Chengming;
- Yao, Yuxin;
- Tang, Xiaoya;
- Yin, Enzhi;
- Lu, Zhiliang;
- Sun, Nan;
- He, Jie
Publication type:
Article
A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogram.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03618-w
By:
- Zhang, Xiaomei;
- Sun, Rui;
- Zhang, Meng;
- Zhao, Yifan;
- Cao, Xinping;
- Guo, Ruiting;
- Zhang, Yi;
- Liu, Xingzhong;
- Lyu, Cuicui;
- Zhao, Mingfeng
Publication type:
Article
Presence of Epstein–Barr virus (EBV) antigens detected by sensitive methods has no influence on local immune environment in diffuse large B cell lymphoma.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03617-x
By:
- Mangiaterra, T.;
- Alonso-Alonso, R.;
- Rabinovich, A.;
- De Dios Soler, M.;
- Galluzzo, L.;
- Soria, M.;
- Colli, S.;
- De Matteo, E.;
- Rodriguez Pinilla, S. M.;
- Chabay, P.
Publication type:
Article
The complex role of IL-10 in malignant ascites: a review.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03616-y
By:
- Huang, Yue;
- Zou, Kangni;
- Jiang, Heng;
- Li, Zhengyu
Publication type:
Article
Characterization of T cell receptor repertoire in penile cancer.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03615-z
By:
- Zhang, Junying;
- Wang, Yapeng;
- Huang, Yiqiang;
- Tan, Xintao;
- Xu, Jing;
- Yan, Qian;
- Tan, Jiao;
- Zhang, Yao;
- Zhang, Jun;
- Ma, Qiang;
- Zhu, Hailin;
- Ye, Jin;
- Zhu, Zhaojing;
- Lan, Weihua
Publication type:
Article
Novel mechanism of drug resistance triggered by tumor-associated macrophages through Heat Shock Factor-1 activation.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03612-2
By:
- Nikotina, Alina D.;
- Vladimirova, Snezhana A.;
- Kokoreva, Nadezhda E.;
- Nevdakha, Valeria A.;
- Lazarev, Vladimir F.;
- Kuznetcova, Liubov S.;
- Komarova, Elena Y.;
- Suezov, Roman V.;
- Efremov, Sergei;
- Leonova, Elizaveta;
- Kartsev, Viktor G.;
- Aksenov, Nikolay D.;
- Margulis, Boris A.;
- Guzhova, Irina V.
Publication type:
Article
An analysis pipeline for understanding 6-thioguanine effects on a mouse tumour genome.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03610-4
By:
- Yankilevich, Patricio;
- Nazerai, Loulieta;
- Willis, Shona Caroline;
- Schmiegelow, Kjeld;
- De Zio, Daniela;
- Nielsen, Morten
Publication type:
Article
Butyricimonas is a key gut microbiome component for predicting postoperative recurrence of esophageal cancer.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03608-y
By:
- Otsuka, Koji;
- Isobe, Junya;
- Asai, Yoshiyuki;
- Nakano, Tomohisa;
- Hattori, Kouya;
- Ariyoshi, Tomotake;
- Yamashita, Takeshi;
- Motegi, Kentaro;
- Saito, Akira;
- Kohmoto, Masahiro;
- Hosonuma, Masahiro;
- Kuramasu, Atsuo;
- Baba, Yuta;
- Murayama, Masakazu;
- Narikawa, Yoichiro;
- Toyoda, Hitoshi;
- Funayama, Eiji;
- Tajima, Kohei;
- Shida, Midori;
- Hirasawa, Yuya
Publication type:
Article
Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03606-0
By:
- Li, Xingchen;
- Tian, Wenzhi;
- Jiang, Zhongxing;
- Song, Yongping;
- Leng, Xiangyang;
- Yu, Jifeng
Publication type:
Article
Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03605-1
By:
- Sharma, Amit;
- Ren, Xiubao;
- Rosato, Antonio;
- Sangiolo, Dario;
- Wang, Zibing;
- Tettamanti, Sarah;
- Zhang, Yi;
- Rettinger, Eva;
- Fenix, Kevin Aaron;
- Sommaggio, Roberta;
- Cappuzzello, Elisa;
- Schmidt-Wolf, Ingo G. H.
Publication type:
Article
CD74 is associated with inflamed tumor immune microenvironment and predicts responsiveness to PD-1/CTLA-4 bispecific antibody in patients with solid tumors.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03604-2
By:
- Wang, Jianghua;
- Li, Xiaoting;
- Xiao, Guanxi;
- Desai, Jayesh;
- Frentzas, Sophia;
- Wang, Zhongmin Maxwell;
- Xia, Yu;
- Li, Baiyong
Publication type:
Article
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03602-4
By:
- Jancewicz, Iga;
- Śmiech, Magdalena;
- Winiarska, Magdalena;
- Zagozdzon, Radoslaw;
- Wisniewski, Pawel
Publication type:
Article
Personalized neoantigen vaccine enhances the therapeutic efficacy of bevacizumab and anti-PD-1 antibody in advanced non-small cell lung cancer.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03598-x
By:
- Lin, Xiuhua;
- Tang, Shichuan;
- Guo, Yutong;
- Tang, Ruijing;
- Li, Zhenli;
- Pan, Xinting;
- Chen, Geng;
- Qiu, Liman;
- Dong, Xiuqing;
- Zhang, Ling;
- Liu, Xiaolong;
- Cai, Zhixiong;
- Xie, Baosong
Publication type:
Article
Unexpected chronic lymphocytic leukemia B cell activation by bisphosphonates.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03588-z
By:
- Mazzarello, Andrea N.;
- Gugiatti, Elena;
- Cossu, Vanessa;
- Bertola, Nadia;
- Bagnara, Davide;
- Carta, Sonia;
- Ravera, Silvia;
- Salvetti, Chiara;
- Ibatici, Adalberto;
- Ghiotto, Fabio;
- Colombo, Monica;
- Cutrona, Giovanna;
- Marini, Cecilia;
- Sambuceti, Gianmario;
- Fais, Franco;
- Bruno, Silvia
Publication type:
Article
Unraveling T cell exhaustion in the immune microenvironment of osteosarcoma via single-cell RNA transcriptome.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03585-2
By:
- Cheng, Debin;
- Zhang, Zhao;
- Liu, Dong;
- Mi, Zhenzhou;
- Tao, Weidong;
- Fu, Jun;
- Fan, Hongbin
Publication type:
Article
Tumor characteristics of dissociated response to immune checkpoint inhibition in advanced melanoma.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03581-6
By:
- Versluis, J. M.;
- Hoefsmit, E. P.;
- Shehwana, H.;
- Dimitriadis, P.;
- Sanders, J.;
- Broeks, A.;
- Blank, C. U.
Publication type:
Article
Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 2, p. 1, doi. 10.1007/s00262-023-03578-1
By:
- Gurrea-Rubio, Mikel;
- Wu, Qi;
- Amin, M. Asif;
- Tsou, Pei-Suen;
- Campbell, Phillip L.;
- Amarista, Camila I.;
- Ikari, Yuzo;
- Brodie, William D.;
- Mattichak, Megan N.;
- Muraoka, Sei;
- Randon, Peggy M.;
- Lind, Matthew E.;
- Ruth, Jeffrey H.;
- Mao-Draayer, Yang;
- Ding, Shengli;
- Shen, Xiling;
- Cooney, Laura A.;
- Lin, Feng;
- Fox, David A.
Publication type:
Article